Abstract P4-22-08: a single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer
Authors
Krop, ICortes, J
Miller, K
Huizing, M
Provencher, L
Gianni, L
Chan, S
Trudeau, M
Steinberg, J
Sugg, J
Liosatos, M
Paton, V
Peterson, A
Wardley, Andrew M
Affiliation
Dana-Farber Cancer Institute, Boston, MAIssue Date
2017-02-14
Metadata
Show full item recordCitation
Abstract P4-22-08: a single-arm phase 2 study to assess clinical activity, efficacy and safety of enzalutamide with trastuzumab in HER2+ AR+ metastatic or locally advanced breast cancer 2017, 77 (4 Supplement):P4-22-08 Cancer ResearchJournal
Cancer ResearchDOI
10.1158/1538-7445.SABCS16-P4-22-08Type
Meetings and ProceedingsLanguage
enISSN
0008-54721538-7445
ae974a485f413a2113503eed53cd6c53
10.1158/1538-7445.SABCS16-P4-22-08